Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-29 Sale | 2025-01-31 5:00 pm | NewAmsterdam Pharma Co N.V. | NAMS | Kling Douglas F Chief Operating Officer | 70,441 | $0 | $0 | 509,868 (Direct) | View |
| 2025-01-27 Sale | 2025-01-29 5:16 pm | NewAmsterdam Pharma Co N.V. | NAMS | Kling Douglas F Chief Operating Officer | 129,559 | $0 | $0 | 662,557 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-29 Exercise | 2025-01-31 5:00 pm | N/A 2031-07-06 | NewAmsterdam Pharma Co N.V. | NAMS | Kling Douglas F Chief Operating Officer | 70,441 | $0 | 509,868 (Direct) | View |
| 2025-01-27 Exercise | 2025-01-29 5:16 pm | N/A 2031-07-06 | NewAmsterdam Pharma Co N.V. | NAMS | Kling Douglas F Chief Operating Officer | 129,559 | $0 | 662,557 (Direct) | View |
| 2025-01-07 Option Award | 2025-01-07 5:10 pm | N/A N/A | NewAmsterdam Pharma Co N.V. | NAMS | Kling Douglas F Chief Operating Officer | 44,000 | $0 | 44,000 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 5:57 pm | N/A 2035-01-02 | NewAmsterdam Pharma Co N.V. | NAMS | Kling Douglas F Chief Operating Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:21 pm | N/A 2034-01-01 | NewAmsterdam Pharma Co N.V. | NAMS | Kling Douglas F Chief Operating Officer | 323,771 | $0 | 323,771 (Direct) | View |
Ownership | 2023-12-29 4:30 pm | N/A 2033-01-01 | NewAmsterdam Pharma Co N.V. | NAMS | Kling Douglas F Chief Operating Officer | 0 | $0 | 1,378,172 (Direct) | View |